Cargando...
Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients
BACKGROUND: Evidence on safety and effectiveness of omalizumab for treatment of chronic urticaria in pediatric patients is scarce and limited to case reports. In particular, drug survival of omalizumab has not yet been investigated, which is a key element in the evaluation of its clinical performanc...
Guardado en:
| Publicado en: | Pediatr Allergy Immunol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248194/ https://ncbi.nlm.nih.gov/pubmed/33305439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pai.13426 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|